BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25816879)

  • 1. Fibrin-based microsphere reservoirs for delivery of neurotrophic factors to the brain.
    Samal J; Hoban DB; Naughton C; Concannon R; Dowd E; Pandit A
    Nanomedicine (Lond); 2015; 10(5):765-83. PubMed ID: 25816879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ionically cross-linked chitosan microspheres for controlled release of bioactive nerve growth factor.
    Zeng W; Huang J; Hu X; Xiao W; Rong M; Yuan Z; Luo Z
    Int J Pharm; 2011 Dec; 421(2):283-90. PubMed ID: 22001532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synergistic effect of nanotopography and sustained dual release of hydrophobic and hydrophilic neurotrophic factors on human mesenchymal stem cell neuronal lineage commitment.
    Teo BK; Tan GD; Yim EK
    Tissue Eng Part A; 2014 Aug; 20(15-16):2151-61. PubMed ID: 24932660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic activity of nerve growth factor slowly released from microspheres.
    Hadlock TA; Sheahan T; Cheney ML; Vacanti JP; Sundback CA
    J Reconstr Microsurg; 2003 Apr; 19(3):179-84; discussion 185-6. PubMed ID: 12806579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of nerve growth factor from fibrin gel.
    Bhang SH; Jeon O; Choi CY; Kwon YH; Kim BS
    J Biomed Mater Res A; 2007 Mar; 80(4):998-1002. PubMed ID: 17117469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of NGF-microsphere conduits for regeneration of defective nerves.
    Sun H; Xu F; Guo D; Yu H
    Neurol Res; 2012 Jun; 34(5):491-7. PubMed ID: 22642924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage.
    Menei P; Pean JM; Nerrière-Daguin V; Jollivet C; Brachet P; Benoit JP
    Exp Neurol; 2000 Jan; 161(1):259-72. PubMed ID: 10683292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix.
    Sakiyama-Elbert SE; Hubbell JA
    J Control Release; 2000 Oct; 69(1):149-58. PubMed ID: 11018553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Layer-by-layer films assembled from natural polymers for sustained release of neurotrophin.
    Zhang Z; Li Q; Han L; Zhong Y
    Biomed Mater; 2015 Sep; 10(5):055006. PubMed ID: 26358683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomaterial-based drug delivery systems for the controlled release of neurotrophic factors.
    Mohtaram NK; Montgomery A; Willerth SM
    Biomed Mater; 2013 Apr; 8(2):022001. PubMed ID: 23385544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release characteristics and bioactivity of gelatin-tricalcium phosphate membranes covalently immobilized with nerve growth factors.
    Chen PR; Chen MH; Lin FH; Su WY
    Biomaterials; 2005 Nov; 26(33):6579-87. PubMed ID: 16023717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly of protein-based hollow spheres encapsulating a therapeutic factor.
    Kraskiewicz H; Breen B; Sargeant T; McMahon S; Pandit A
    ACS Chem Neurosci; 2013 Sep; 4(9):1297-304. PubMed ID: 23763540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged controlled delivery of nerve growth factor using porous silicon nanostructures.
    Zilony N; Rosenberg M; Holtzman L; Schori H; Shefi O; Segal E
    J Control Release; 2017 Jul; 257():51-59. PubMed ID: 27988302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A drug delivery system based on alginate microspheres: mass-transport test and in vitro validation.
    Ciofani G; Raffa V; Menciassi A; Micera S; Dario P
    Biomed Microdevices; 2007 Jun; 9(3):395-403. PubMed ID: 17252208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel polymeric drug delivery system for localized and sustained release of tacrolimus (FK506).
    Tajdaran K; Shoichet MS; Gordon T; Borschel GH
    Biotechnol Bioeng; 2015 Sep; 112(9):1948-53. PubMed ID: 25850693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of aggregation-resistant biocompatible superparamagnetic noncovalent hybrid multilayer hollow microspheres for controlled drug release.
    Zhao X; Du P; Liu P
    Mol Pharm; 2012 Nov; 9(11):3330-9. PubMed ID: 22931055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres.
    Layman H; Li X; Nagar E; Vial X; Pham SM; Andreopoulos FM
    J Biomater Sci Polym Ed; 2012; 23(1-4):185-206. PubMed ID: 21192837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels.
    Burdick JA; Ward M; Liang E; Young MJ; Langer R
    Biomaterials; 2006 Jan; 27(3):452-9. PubMed ID: 16115674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silk fibroin matrices for the controlled release of nerve growth factor (NGF).
    Uebersax L; Mattotti M; Papaloïzos M; Merkle HP; Gander B; Meinel L
    Biomaterials; 2007 Oct; 28(30):4449-60. PubMed ID: 17643485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NGF-conjugated iron oxide nanoparticles promote differentiation and outgrowth of PC12 cells.
    Marcus M; Skaat H; Alon N; Margel S; Shefi O
    Nanoscale; 2015 Jan; 7(3):1058-66. PubMed ID: 25473934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.